Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)-Reference-Cited by-同舟云学术

Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)

Published:2008-01 Issue:1 Volume:44 Page:25-29
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Booth Christopher M.,Calvert A. Hilary,Giaccone Giuseppe,Lobbezoo Marinus W.,Eisenhauer Elizabeth A.,Seymour Lesley K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. Booth CM, Calvert AH, Giaccone G, Lobbezoo MW, Seymour LK, Eisenhauer EA. Endpoints in phase I studies of targeted anticancer therapy: report of the task force on methodology for the development of innovative cancer therapies (MDICT). Eur J Cancer 2007, in press.

2. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

3. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002

4. Application of a new multinomial phase II stopping rule using response and early progression;Dent;J Clin Oncol,2001

5. Design issues of randomized phase II trials and a proposal for phase II screening trials;Rubinstein;J Clin Oncol,2005

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations;ESMO Open;2024-08

2. Bypassing phase 2 in cancer drug development erodes the risk/benefit balance in phase 3 trials;Journal of Clinical Epidemiology;2023-06

3. Evolution of Phase II Oncology Trial Design: from Single Arm to Master Protocol;Therapeutic Innovation & Regulatory Science;2023-03-04

4. Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022;Annals of Oncology;2023-01

5. Data augmentation based on waterfall plots to increase value of response data generated by small single arm Phase II trials;Contemporary Clinical Trials;2021-11